| (Values in U.S. Thousands) | Jun, 2021 | Jun, 2020 | Jun, 2019 | Jun, 2017 | Jun, 2016 |
| Sales | 704,710 | 635,820 | 595,930 | 383,410 | 504,480 |
| Sales Growth | +10.83% | +6.69% | +55.43% | -24.00% | unch |
| Net Income | 40,780 | 17,270 | 6,780 | 4,820 | 20,040 |
| Net Income Growth | +136.13% | +154.72% | +40.66% | -75.95% | unch |
Clinigen Group Plc (CLIGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Clinigen Group plc is a pharmaceutical and services company. Its business focuses in areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen Group plc is headquartered in Burton-on-Trent, the United Kingdom.
Fiscal Year End Date: 06/30